Biomarker Analysis for Survival Prediction With Avelumab Maintenance in Advanced Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Avelumab Maintenance in Advanced Urothelial Carcinoma: Biomarker Analysis of the Phase 3 JAVELIN Bladder 100 Trial
Nat. Med. 2021 Dec 01;27(12)2200-2211, T Powles, SS Sridhar, Y Loriot, J Bellmunt, XJ Mu, KA Ching, J Pu, CN Sternberg, DP Petrylak, R Tambaro, LM Dourthe, C Alvarez-Fernandez, M Aarts, A di Pietro, P Grivas, CB DavisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.